RE: Full Case Study Document AVA61039 Feb 2025 12:02
Back on the day Alan used Ablynx as his exemplar, similar to an affimer platform that sold for billions. The best one now is Prometheus Biosciences, precision tech, they proved their platform on a major target to draw out BP, sold for more billions. All that’s needed is patience. It’s been years, a few more won’t hurt.
Queue standard boring replies… aah, but they’ll run out of cash, it’s only Ribena. As if there aren’t any specialist investors waiting in the wings and as if the science doesn’t continue to impress. Waaaah, but that’s dilution. Yes, ribena needs diluting. 50% of many billions can be worth more than 100% of a couple.
They’ll sell Dx, they’ll list on Nasdaq, they’ll get investment, clinical development will continue and at some point they’ll get taken over. Unless you’re getting paid 20p per post, don’t waste your time on trolls.
Posting again, it’s a beauty:
https://youtu.be/v5kstO1R2vA?si=gA1nrIv6EDnH_jjs